• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶的构象可塑性

The conformational plasticity of protein kinases.

作者信息

Huse Morgan, Kuriyan John

机构信息

Department of Biological Sciences, Stanford University, Palo Alto, California 94305, USA.

出版信息

Cell. 2002 May 3;109(3):275-82. doi: 10.1016/s0092-8674(02)00741-9.

DOI:10.1016/s0092-8674(02)00741-9
PMID:12015977
Abstract

Protein kinases operate in a large number of distinct signaling pathways, where the tight regulation of their catalytic activity is crucial to the development and maintenance of eukaryotic organisms. The catalytic domains of different kinases adopt strikingly similar structures when they are active. By contrast, crystal structures of inactive kinases have revealed a remarkable plasticity in the kinase domain that allows the adoption of distinct conformations in response to interactions with specific regulatory domains or proteins.

摘要

蛋白激酶在大量不同的信号通路中发挥作用,其催化活性的严格调控对于真核生物的发育和维持至关重要。不同激酶的催化结构域在激活时具有惊人相似的结构。相比之下,非活性激酶的晶体结构显示出激酶结构域具有显著的可塑性,这使得它们能够根据与特定调节结构域或蛋白质的相互作用而采用不同的构象。

相似文献

1
The conformational plasticity of protein kinases.蛋白激酶的构象可塑性
Cell. 2002 May 3;109(3):275-82. doi: 10.1016/s0092-8674(02)00741-9.
2
Activation of a serine/threonine kinase signaling pathway by transforming growth factor type beta.转化生长因子β激活丝氨酸/苏氨酸激酶信号通路。
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12110-4. doi: 10.1073/pnas.92.26.12110.
3
Theme and variations: juxtamembrane regulation of receptor protein kinases.主题与变奏:受体蛋白激酶的近膜调节
Mol Cell. 2001 Sep;8(3):481-2. doi: 10.1016/s1097-2765(01)00350-1.
4
Classifying kinase conformations using a machine learning approach.使用机器学习方法对激酶构象进行分类。
BMC Bioinformatics. 2017 Feb 2;18(1):86. doi: 10.1186/s12859-017-1506-2.
5
Novel protein kinases and molecular mechanisms of autoinhibition.新型蛋白激酶与自身抑制的分子机制
Curr Opin Struct Biol. 2004 Dec;14(6):700-5. doi: 10.1016/j.sbi.2004.10.011.
6
Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification.蛋白激酶6. 真核生物蛋白激酶超家族:激酶(催化)结构域结构与分类。
FASEB J. 1995 May;9(8):576-96.
7
SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.SB-431542是一种强效、特异性的转化生长因子-β超家族I型激活素受体样激酶(ALK)受体ALK4、ALK5和ALK7的抑制剂。
Mol Pharmacol. 2002 Jul;62(1):65-74. doi: 10.1124/mol.62.1.65.
8
Identification of a hidden strain switch provides clues to an ancient structural mechanism in protein kinases.鉴定一种隐藏的构象转变提供了蛋白质激酶古老结构机制的线索。
Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):924-9. doi: 10.1073/pnas.1207104110. Epub 2012 Dec 31.
9
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.受体酪氨酸激酶信号传导的特异性:短暂与持续的细胞外信号调节激酶激活
Cell. 1995 Jan 27;80(2):179-85. doi: 10.1016/0092-8674(95)90401-8.
10
PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle.丙酮酸脱氢酶激酶2:受体酪氨酸激酶信号通路谜题中缺失的一环。
Am J Physiol Endocrinol Metab. 2005 Aug;289(2):E187-96. doi: 10.1152/ajpendo.00011.2005.

引用本文的文献

1
A structure-based tool to interpret the significance of kinase mutations in clinical next generation sequencing in cancer.一种基于结构的工具,用于解读癌症临床下一代测序中激酶突变的意义。
Front Oncol. 2025 Aug 4;15:1599389. doi: 10.3389/fonc.2025.1599389. eCollection 2025.
2
A molecular dynamics protocol for rapid prediction of EGFR overactivation and its application to the rare mutations S768I, S768N, D761N.一种用于快速预测表皮生长因子受体(EGFR)过度激活的分子动力学方案及其在罕见突变S768I、S768N、D761N中的应用
Comput Struct Biotechnol J. 2025 Jul 30;27:3370-3378. doi: 10.1016/j.csbj.2025.07.046. eCollection 2025.
3
In-silico drug repositioning studies of Candida albicans Nitrogen permease reactivator 1 (Npr1) kinase.
白色念珠菌氮通透酶激活剂1(Npr1)激酶的计算机辅助药物重新定位研究
Sci Rep. 2025 Jul 2;15(1):23626. doi: 10.1038/s41598-025-08148-2.
4
Dual-specific autophosphorylation of kinase IKK2 enables phosphorylation of substrate IκBα through a phosphoenzyme intermediate.激酶IKK2的双特异性自磷酸化通过磷酸酶中间体使底物IκBα发生磷酸化。
Elife. 2025 Jun 30;13:RP98009. doi: 10.7554/eLife.98009.
5
Current progress in targeting mitotic kinases in PDAC.胰腺癌中靶向有丝分裂激酶的当前进展。
RSC Med Chem. 2025 Jun 19. doi: 10.1039/d5md00162e.
6
Allosteric Coupling in Full-Length Lyn Kinase Revealed by Molecular Dynamics and Network Analysis.分子动力学和网络分析揭示全长Lyn激酶中的变构偶联
Int J Mol Sci. 2025 Jun 18;26(12):5835. doi: 10.3390/ijms26125835.
7
Unveiling the Mechanistic Impact of Mutations F2004C/V in the ROS1 Kinase Domain.揭示ROS1激酶结构域中F2004C/V突变的机制影响。
ACS Omega. 2025 May 30;10(22):22837-22846. doi: 10.1021/acsomega.5c00072. eCollection 2025 Jun 10.
8
Structure-Based Design of Potent and Selective MerTK Inhibitors by Modulating the Conformation of αC Helix.通过调节αC螺旋构象进行强效和选择性MerTK抑制剂的基于结构的设计
J Med Chem. 2025 Jun 12;68(11):10877-10896. doi: 10.1021/acs.jmedchem.4c03092. Epub 2025 May 20.
9
Probing structural requirements for thiazole-based mimetics of sunitinib as potent VEGFR-2 inhibitors.探究基于噻唑的舒尼替尼模拟物作为强效VEGFR-2抑制剂的结构要求。
RSC Med Chem. 2025 Jan 22. doi: 10.1039/d4md00754a.
10
The molecular basis of Human FN3K mediated phosphorylation of glycated substrates.人类FN3K介导的糖基化底物磷酸化的分子基础。
Nat Commun. 2025 Jan 22;16(1):941. doi: 10.1038/s41467-025-56207-z.